Health Alert: Hormone Therapy Associated with Ovarian Cancer Risk.
The risk for developing the two most common forms of ovarian cancer appears to be associated with the use of hormone replacement therapy (HRT) for menopause. According to Dr. Richard Peto, “For women who take HRT for 5 years from around age 50, there will be about one extra ovarian cancer for every 1,000 users and one extra ovarian cancer death for every 1,700 users.” The increase in risk was only found for serous and endometrioid ovarian cancers, which are the two main types of ovarian cancer. HRT does not appear to increase a user’s risk for mutinous and clear cell ovarian cancers. The Lancet, February 2015